The keys to successful CDMO collaboration during development

When drug development companies prepare to enter the clinical phase, they must produce both the Drug Substance (API) and the Drug Product (IMP). Since many organizations lack the in-house capabilities for this, they often turn to Contract Development and Manufacturing Organizations (CDMOs) to handle the production.

How can you successfully source these services and select the CDMO best suited to your needs? Join us to hear from speakers with experience in contracting and working with CDMOs and gain valuable insights into best practices and strategies.